Jiangsu Hengrui Pharmaceuticals Co.,Ltd
600276.SS
Abajo encontrarás el precio en vivo de Jiangsu Hengrui Pharmaceuticals Co.,Ltd (600276.SS), un gráfico de 1 año, 8 indicadores (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volumen) y el modo de comparación. Puedes añadir a tu cartera, marcar como favorito o configurar alertas de precio.
- Prev close
- $6.43
- Volume
- $9.59M
- Market cap
- $43.65B
- Currency
- USD (native CNY)
Financials
- 52w high
- ¥74.04
- 52w low
- ¥47.20
- 52w change
- -12.40%
- Day high
- ¥48.72
- Day low
- ¥47.37
- P/E (TTM)
- 39.05
- Forward P/E
- 27.6
- PEG
- 0.93
- Price / Book
- 5.03
- Beta (5Y)
- 0.17
- Enterprise value
- 272.96B
- EV / Revenue
- 8.38
- EV / EBITDA
- 28.88
- EPS (TTM)
- ¥1.22
- Forward EPS
- ¥1.73
- Dividend yield
- 0.43%
- Dividend rate
- ¥0.20
- Payout ratio
- 16.39%
- Revenue (TTM)
- 32.56B
- EBITDA
- 9.45B
- Free cash flow
- 6.31B
- Total cash
- 40.64B
- Total debt
- 67.47M
- Debt / Equity
- 0.11
- Current ratio
- 9.23
- Quick ratio
- 8.36
- Profit margin
- 24.93%
- Gross margin
- 86.27%
- Return on assets
- 8.80%
- Return on equity
- 14.54%
- Shares outstanding
- 6.38B
- Float
- 3.77B
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Analyst & Risk
- Beta (vs S&P 500)
- 0.17
- very stable
- 52-week change
- -12.40%
- Debt / Equity
- 0.11
- low leverage
- Current ratio
- 9.23
- Quick ratio
- 8.36
- ROE
- 14.54%
- ROA
- 8.80%
- PEG ratio
- 0.93
- potentially undervalued
- EV / Revenue
- 8.38
- EV / EBITDA
- 28.88
- Revenue growth
- 13.00%
- Earnings growth
- 13.30%
- EBITDA
- 9.45B
- Free cash flow
- 6.31B
- Total cash
- 40.64B
- Total debt
- 67.47M
- Insider holdings
- 46.26%
- Institutional
- 16.59%
Noticias recientes
- Uber reveals an unexpected problem behind the AI boomTheStreet6m ago
- NMAA board approves 'one free transfer' rule; schools get final sayAlbuquerque Journal, N.M.8m ago
- New Mexico's AG files suit against sports betting firm KalshiAlbuquerque Journal, N.M.10m ago
- Why Ollie's (OLLI) Shares Are Sliding TodayStockStory11m ago
- Microsoft Held Up as AI Chips Sold Off. Is It the Safer Megacap Bet Now?Motley Fool12m ago
- Mitsubishi Electric to Launch Data-provision Service to Accelerate Adoption of Latest Power SemiconductorsBusiness Wire13m ago
- Kupcho seizes slim lead in US Women's Open at RivieraAFP14m ago
- Dow Jones Futures: Techs Fall After Dow Hits High, AI Shrugs Off Broadcom, Ciena; Jobs Report LoomsInvestor's Business Daily6m ago
Discusión en vivo
Iniciar sesión to join the discussion.
- Aún no hay comentarios. Sé el primero.